Department of Clinical Immunology, Dalian Medical University, China.
Vaccine. 2012 May 14;30(23):3483-7. doi: 10.1016/j.vaccine.2012.02.053. Epub 2012 Mar 18.
The purpose of the study was to quantitatively evaluate the effect of the hepatitis B vaccine based on 33 years of data published on the HBsAg- and anti-HBs-positive rates.
All data were obtained from studies in published Chinese scientific journals from 1977 to 2009. The HBsAg- or anti-HBs-positive rate over a certain observation period was presented.
When the anti-HBs-positive rate was low, the ability of anti-HBs to control the HBsAg-positive rate is not apparent. When the anti-HBs level is high, the ability of anti-HBs to control the HBsAg-positive rate increases gradually, and a linear relationship was observed between the HBsAg-positive rate and the anti-HBs-positive rate. However, the rate of decrease of HBsAg positivity was markedly higher than the theoretical rate.
The effect of other known or unknown factors, in addition to the vaccination campaign, could have contributed to the decrease in the prevalence of HBV infection.
本研究旨在通过 33 年的 HBsAg 和抗-HBs 阳性率数据,定量评估乙型肝炎疫苗的效果。
所有数据均来自于 1977 年至 2009 年发表在中国科学期刊上的研究。在一定的观察期内,呈现 HBsAg 或抗-HBs 阳性率。
当抗-HBs 阳性率较低时,抗-HBs 控制 HBsAg 阳性率的能力并不明显。当抗-HBs 水平较高时,抗-HBs 控制 HBsAg 阳性率的能力逐渐增强,并且在 HBsAg 阳性率和抗-HBs 阳性率之间观察到线性关系。然而,HBsAg 阳性率的下降速度明显高于理论速度。
除了疫苗接种活动之外,其他已知或未知因素可能对 HBV 感染流行率的下降做出了贡献。